Introduction: Gastroparesis is common in intensive care patients and may increase the incidence of malnutrition and nosocomial pneumonia, leading to poorer patient outcomes. Current pharmacotherapy has shown only modest efficacy. Acupuncture without pharmacotherapy has been shown to improve gastroparesis in animal studies and in recent clinical trials. However, no trials studying the efficacy of acupuncture as an adjunctive therapy for surgical intensive care patients have been done. This study aims to evaluate the effectiveness of adding electro-acupuncture therapy to pharmacotherapy in the management of gastroparesis in these patients.
INTRODUcTION
It is important that critically ill patients receive adequate nutrition as malnutrition is associated with increased mortality as well as difficulty weaning and longer hospital length-of-stay 1,2 . Early enteral feeding has been shown to be beneficial as it decreases stress ulcers and improves gastrointestinal immunity through improved mucosal circulation. It is also cheaper and associated with less infective complications than parenteral feeding [2] [3] [4] . A common problem with enteral feeding is delayed gastric emptying, which affects approximately half of all critically ill patients 4, 5 . If unresolved, it may result in abdominal distension, constipation and malnutrition which may impair wound healing as well as increased incidence of reflux and nosocomial pneumonia 2, 4 . Thus improvement in gastric emptying will potentially help in patient recovery as well as avoidance of nosocomial infections.
Proceedings of Singapore Healthcare  Volume 21  Number 3  2012 Management of delayed gastric emptying in the critically ill includes prokinetic therapy, post-pyloric feeding or total parenteral nutrition. Prokinetic therapy, be it monotherapy or combination therapy, remains first line treatment and has shown only modest efficacy with a resolution rate of 30-50% [2] [3] [4] [5] . The most widely used prokinetic drugs are metoclopramide and erythromycin 4 .
Acupuncture has been shown to have potential in improving gastric emptying in recent clinical trials in critically ill patients 6 and post-abdominal surgical patients 7 as well as animal studies 8, 9 . If proven to be effective, acupuncture has the added benefit of having almost no known adverse effects.
The trial by Pfab et al 6 was performed on critically ill neurosurgical patients, and patients with intraabdominal surgery were excluded. However, it is precisely this group of patients who commonly have delayed gastric emptying that persist despite prokinetic therapy.
A trial by Sun et al 7 was performed on post-hepatic resection surgery non-intensive care patients with gastroparesis. It compared metoclopramide and acupuncture, which demonstrated a significant improvement in cure rate in favour of acupuncture.
As there is limited information on the effectiveness of acupuncture in the treatment of gastroparesis in the critically ill, including post-abdominal surgery patients, the aim of the current study is to evaluate the effectiveness of acupuncture with electro-stimulation as an adjunctive therapy for gastroparesis in surgical intensive care patients. Electro-acupuncture is a therapy which combines needling and electric stimulation by applying a small amount of electric current to the inserted needle. By adding electro-stimulation or using electro-acupuncture, we will be able to objectively control the frequency and intensity of stimulation as well as the duration of stimulation.
METHODS

Study Design
The study is a prospective, block randomised, nonblinded trial comparing the 48 hours effectiveness of acupuncture with electro-stimulation with metoclopramide and metoclopramide alone in resolving delayed gastric emptying in surgical intensive care patients. Approval of the Singhealth IRB was obtained. Written consent would be sought by the patient's legally acceptable representative.
Subjects
We seek to enroll 100 patients per group. Basing our calculations from previous reports on success rates of metoclopramide 2,4-6 , an estimate of 50% resolution of gastrointestinal motility with 8 hourly of 20 mg intravenous metoclopramide was derived. With the addition of acupuncture therapy, we estimate the beneficial effect on gastrointestinal motility to be an additional 20%. Using α value of 0.05, power of 80%, we will require 93 patients per group.
Given the incidence of gastroparesis and the number of patients required, the authors aim to complete the study in three years.
The inclusion criteria are adult patients from 21-85 years old, who are mechanically ventilated and have commenced naso-gastric or oro-gastric tube enteral feeding protocol and with gastroparesis. We defined gastroparesis as two consecutive gastric residual volume of more than 120 mL aspirated four hours apart in patients undergoing the enteral feeding protocol.
We exclude patients in whom enteral feeding is contra-indicated (such as for post-operative surgical reasons, suspected or established perforated viscus, pancreatitis or bowel obstruction), patients in whom needle acupuncture is contra-indicated (such as infection, or broken skin, or having a wound or dressing over any of the stated acupoints to be used), patients in whom naso-gastric or orogastric tube insertion is contraindicated, a history of partial or total gastrectomy and known allergy to metoclopramide.
Protocol
All patients in the intensive care unit are placed on the enteral feeding protocol when starting feeds. This dictates the rate of continuous feeding as well as the circumstances to increase or decrease feeding rates. Gastric residual volumes are checked every four hours. The type of feeds and target caloric intake per day is determined by the intensivist-in-charge.
When a patient is found to have feed intolerance, feeding is stopped and the patient is examined Proceedings of Singapore Healthcare  Volume 21  Number 3  2012 to exclude serious intra-abdominal pathology. Further investigations may be pursued to exclude mechanical obstruction and pancreatitis, and electrolytes corrected at the discretion of the intensive care team. Patients who satisfy the inclusion and exclusion criteria are invited to participate in the trial. Upon recruitment, patients are allocated into one of two groups: Acupuncture with metoclopramide or metoclopramide alone. Computer generated randomisation is used to allocate recruited patients and the randomisation list maintained by a clinical research coordinator not involved in the process of recruitment of patients.
In both groups, therapy is performed for 48 hours. In Group M, subjects receive IV metoclopramide 20 mg, eight hourly for 48 hours or until gastroparesis resolves. In Group A, subjects receive IV metoclopramide 20 mg, eight hourly and receive electrostimulation with needle acupuncture of all the following acupoints: Zusanli (ST36), Tianshu (ST25), Gongsun (SP4) and Neiguan (PC6).
Electro-acupuncture
is performed twice daily up to four sessions with each session lasting thirty minutes. They are performed by accredited acupuncturists.
We will analyse the 24-hour gastric residual volumes at 24 hours and 48 hours after the commencement of therapy. Resolution of gastroparesis is defined as gastric residual volume of less than 200 mL over a 24-hour period. Information on electrolytes and sedative and analgesic medications will also be recorded. If acupuncture is instituted, haemodynamic parameters will be charted.
RESULTS
To date, three patients have been recruited, with two in Group A and one in Group M. All subjects met the study criteria for resolution of gastroparesis at 48 hours.
The number of surgical patients admitted to the intensive care unit over the four-month period from the time of recruitment (March 2012) was 220. Of these, 92 patients stayed in the unit longer than two days.
There were a total of eight patients whose gastric residual volumes met the criteria for gastroparesis.
Of these, two were to be extubated imminently and thus would not meet our inclusion criteria.
Another two patients were on calorically dense enteral formulae. The authors had initially excluded patients on calorically dense enteral formulae because it was believed that the restricted volumes fed would confound the results with regards to the resolution of gastroparesis. That is, the lower volumes administered would make it easier to meet the criteria for gastroparesis resolution since there would be lower volumes that could be retained. However, approximately half of the patients in the unit were on calorically dense enteral formulae for a variety of reasons, the most common being renal failure requiring renal replacement therapy. It was concluded that excluding such patients would not only affect recruitment, but also the applicability of the study, given the high rates of renal failure in critically ill patients. Singhealth IRB has granted permission for the change in protocol to include patients on calorically dense enteral formulae.
The remaining patient was not considered for the study as the therapeutic goals shifted to a palliative emphasis for end-of-life care and it was deemed inappropriate to enroll such a patient for an experiment involving a small, but nonetheless invasive procedure like acupuncture, with no guarantee of alleviating the patient's suffering.
By using only the 92 longer stayers in the intensive care unit as the denominator, the incidence of gastroparesis was 8.7% over the four-month period.
DIScUSSION
Only three patients have been enrolled in the study so far. Despite this small number, we will be making progressive analysis and reports as more patients are recruited.
Given that the estimated incidence of gastroparesis in the critically ill is 50%, the low incidence is surprising. The authors are confident that the reasons for this will become clearer as the study progresses. However, based on current information, we can only offer some explanations for the supposed low incidence of gastroparesis.
Firstly, there is no standard definition of gastroparesis or feed intolerance. The study's enteral feeding protocol and definition of Proceedings of Singapore Healthcare  Volume 21  Number 3  2012 gastroparesis borrows heavily from the unit's preexisting enteral feeding protocol. The authors chose this as the protocol is consistent with the ASPEN/SCCM guidelines 10 as well as guidelines from other societies 11, 12 . Moreover, it would reduce the need to re-train and re-educate the current intensive care unit staff on a new feeding protocol, making the protocol easier to implement.
It is debatable whether the study's definition of gastroparesis is too stringent, thus reducing the pool of recruitable patients. It is notable that most guidelines invoke a gastric residual volume of 250-500 mL as significant to warrant cessation of feeds, whereas this study's protocol requires a residual volume of only 120 mL, albeit twice at a four-hour interval.
Secondly, despite implementation of a feeding protocol, feeding targets are seldom met in critically ill patient, even when the protocol is adhered to. Apart from feed intolerance, cessation of feeding occurs not infrequently for many reasons 10 including fasting for surgical procedures or a trial of extubation. The failure to meet feeding targets would translate to lower feeding volumes and possibly lower gastric residual volumes.
Thirdly, in critical care, patients' conditions are highly dynamic. There were at least two patients in whom the gastric residual volumes were high, but were successfully extubated before they could be enrolled. We also reported on the patient whose condition deteriorated to a point where withdrawal of therapy was instituted, thus making recruitment ethically tenuous.
Critically ill patients are also notoriously difficult to recruit as the patients frequently lack the mental capacity at the time of the study to give informed consent since their mental faculties would be influenced by many factors, including their severe illness and the use of sedative medications. Informed consent must be sought from the patient's legally acceptable representative who may not be available or contactable. So far, with the small number of patients who have been eligible for the study, the authors have yet to face this problem. It must be noted, however, that the study by Pfab et al was granted a waiver of informed consent, which would certainly improve the recruitment rate. This would be unacceptable locally, given the ethical as well as medico-legal implications in the local medical culture.
At present, acupuncture in general is still considered as an alternative or complimentary therapy. While there is a growing body of literature regarding its use, there is still insufficient evidence in terms of well-designed randomised control trials. One issue pertains to the use of "sham" acupuncture points. On the surface, this appears to be an elegant solution to establish blinding for both patients and investigators, thus eliminating any biases or differences due to the placebo effect. However, according to traditional acupuncture theory, sham points do not exist. The Meridian or Channel theory asserts that needling at an alternative point may not be the most efficacious, but there will be an effect nonetheless.
In this study, acupuncture is offered as an adjunct because it has yet to be accepted as conventional therapy and ethical issues would be raised if given as monotherapy.
There are some implications if adjunctive therapy is found to be effective. Firstly, it may become established as an acceptable second line therapy for patients who have failed a trial of metoclopramide therapy. As mentioned previously, metoclopramide and erythromycin are the most commonly used prokinetic agents in critically ill patients 4 . Although erythromycin has been shown to be at least as effective as metoclopramide 2,4,5 , and has proven synergy with metoclopramide when used as a "rescue" therapy in patients who remain feed intolerant on monotherapy 2 , it is prescribed cautiously as the sub-inhibitory doses of this antimicrobial used for the treatment of gastroparesis can increase the risk of antibiotic resistance and Clostridium difficile infection 2 . Furthermore, erythromycin is associated with arrhythmias and being an inhibitor of the 3A isoform sub-family of the cytochrome p450 enzyme system, raises the prospect of significant drug interactions in critically ill patients who are typically subject to poly-pharmacy.
Acupuncture, being non-pharmacological, avoids any drug interactions. There are no known physiological adverse effects associated with acupuncture and if done by a trained acupuncturist with very fine 32 gauge needles and appropriate standards of Proceedings of Singapore Healthcare  Volume 21  Number 3  2012 sterility, the risks of infection and bleeding are extremely low.
Secondly, the success of adjunctive therapy may permit the study of acupuncture as monotherapy with direct comparison to metoclopramide. If it is found to be as effective as metoclopramide, the intensivist may consider it as first line therapy to avoid the known adverse effects and drug interactions associated with metoclopramide. If the superiority of acupuncture is proven, it may even replace metoclopramide or erythromycin as first line therapy.
If adjunctive therapy does not prove to be better than metoclopramide alone, the conclusion would be that there is no synergism between metoclopramide and acupuncture for the treatment of gastroparesis in the critically ill. The question of whether acupuncture would be effective as monotherapy would still remain.
The study of the use of acupuncture in the treatment of critically ill patients with gastroparesis is worthwhile due to its excellent side-effect profile and if successful, will be a tool to improve nutritional support, which is a crucial element in the care and management of such patients.
